Firefly Neuroscience (AIFF) Other Operating Expenses (2023 - 2026)

Firefly Neuroscience's Other Operating Expenses history runs 4 years deep, the most recent figure standing at -$2.1 million for Q1 2026.

• On a quarterly basis, Other Operating Expenses fell 767.63% year-over-year to -$2.1 million in Q1 2026; TTM through Mar 2026 was $5.3 million, a 228.46% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, down 49.35% from the prior year.
• Other Operating Expenses eased to -$2.1 million in Q1 2026 per AIFF's latest filing, from $6.5 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $6.5 million in Q4 2025 and bottomed at -$2.1 million in Q1 2026.
• The 4-year median for Other Operating Expenses is $530000.0 (2025), against an average of $1.1 million.
• Across the five-year window, Other Operating Expenses soared 30.8% in 2024 and sank 767.63% in 2026, its largest moves.
• Year by year, Other Operating Expenses stood at $1.0 million in 2023, then jumped by 30.8% to $1.3 million in 2024, then soared by 399.85% to $6.5 million in 2025, then plunged by 131.86% to -$2.1 million in 2026.
• Per Business Quant, the three latest AIFF Other Operating Expenses figures stand at -$2.1 million (Q1 2026), $6.5 million (Q4 2025), and $530000.0 (Q3 2025).